Leaps by Bayer
Germanyleaps.bayer.com
Overview
Leaps by Bayer is the strategic impact investment unit of Bayer. By accelerating transformative biotechnologies, they aim to shift key paradigms in life science, changing the world for better . In health, they pursue breakthroughs that could set new standards in medical care, moving from treating symptoms to curing or preventing diseases. In agriculture, they drive innovations that could nourish a growing population while restoring the planet .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sabanto | Jul 2026 | Series B | Lead |
| Sonotherapeutics Inc. | Jun 2026 | Series B | Co-investor |
| EarthOptics | May 2026 | Series C | Co-investor |
| Ukko | Jan 2026 | Series C | Co-investor |
| WellTheory | Oct 2025 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
